Pelthos Therapeutics PTHS
NYSE PTHS
$20.66 -0.35 (-1.67%)
As of: Oct 1, 2026 · 3:53 PM EDT

Pelthos Therapeutics (PTHS) Change in Receivables (2026)

Updated

Pelthos Therapeutics' Change in Receivables came in at $2.78 million for Q2 2026, down 2.1% from the prior quarter.

Analysis

Pelthos Therapeutics (PTHS) Change in Receivables (2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Pelthos Therapeutics reported Change in Receivables of $5.62 million; for FY2025, it was $8.81 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.35 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.37 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 333.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 140.20 Mn
10 Pelthos Therapeutics 79.95 Mn -8.44 Mn 11.99 Mn 2.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.78 Mn
Mar 31, 2026 2.84 Mn
API Access

Pelthos Therapeutics Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=PTHS&period=max&api_key=YOUR_API_KEY